Thus, although none of the described GRPR- and PSMA-bispecific agents have been studied in a clinical context thus far, some of the developed radiotracers demonstrated high potential for bispecific and therefore highly sensitive PCa imaging during all stages of disease. The gene discussed is GRPR; the disease is posterior cortical atrophy.